Comparison of first-line chemotherapy based on irinotecan or other drugs to treat non-small cell lung cancer in stage IIIB/IV: a systematic review and meta-analysis

BACKGROUND: To compare the efficacy and toxicity of irinotecan-based chemotherapy (IBC) and non-irinotecan-based chemotherapy (NIBC) as first-line treatment for stage IIIB/IV non-small cell lung cancer (NSCLC). METHODS: PubMed, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), ab...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xue-Qin, Li, Chong-Yi, Xu, Ming-Fang, Zhao, Hong, Wang, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682247/
https://www.ncbi.nlm.nih.gov/pubmed/26673747
http://dx.doi.org/10.1186/s12885-015-1978-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682247/
https://www.ncbi.nlm.nih.gov/pubmed/26673747
http://dx.doi.org/10.1186/s12885-015-1978-2

Ejemplares similares